Stock listing
NASDAQ:NMRA Neumora Therapeutics, Inc. Stock
Home listing (NASDAQ) of Neumora Therapeutics, Inc.
Follow Neumora Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:NMRA
$0.367 USD -0.021 (-5.4%)
Close on Oct 30, 2026
- Day range
- $0.353 – $0.410 USDOct 30, 2026
- Volume
- 1.11M sharesOct 30, 2026
- Market cap
- $69.00M USDAt the close on Oct 30, 2026 · price × 187.9M shares outstanding
- 52-week range
- $0.315 – $3.650 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $1.13M USDMedian day 1.14M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:NMRA · Home | $0.367 USD | -0.021 (-5.4%) | 1,106,454 | $0.407 | $0.410 | $0.353 | $0.388 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:NMRA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.367 | -0.021 | -5.4% | $0.407 | $0.410 | $0.353 | 1,106,454 | |
| $0.388 | -0.005 | -1.2% | $0.397 | $0.410 | $0.368 | 1,383,491 | |
| $0.393 | +0.025 | +6.8% | $0.366 | $0.396 | $0.361 | 1,121,759 | |
| $0.368 | -0.025 | -6.3% | $0.389 | $0.421 | $0.361 | 1,738,476 | |
| $0.393 | +0.014 | +3.7% | $0.387 | $0.430 | $0.374 | 512,157 | |
| $0.379 | -0.027 | -6.7% | $0.399 | $0.414 | $0.366 | 830,800 | |
| $0.406 | -0.010 | -2.4% | $0.430 | $0.435 | $0.387 | 863,500 | |
| $0.416 | -0.049 | -10.5% | $0.470 | $0.476 | $0.406 | 1,577,500 | |
| $0.465 | -0.005 | -1.1% | $0.480 | $0.496 | $0.457 | 974,300 | |
| $0.470 | -0.004 | -0.8% | $0.468 | $0.505 | $0.460 | 1,647,200 | |
| $0.474 | +0.047 | +11.0% | $0.437 | $0.506 | $0.420 | 3,524,400 | |
| $0.427 | +0.072 | +20.3% | $0.365 | $0.460 | $0.360 | 6,461,500 | |
| $0.355 | -0.015 | -4.1% | $0.390 | $0.400 | $0.315 | 2,797,500 | |
| $0.370 | -0.067 | -15.3% | $0.430 | $0.435 | $0.367 | 1,492,100 | |
| $0.437 | -0.039 | -8.2% | $0.482 | $0.482 | $0.436 | 1,210,400 | |
| $0.476 | -0.004 | -0.8% | $0.470 | $0.510 | $0.470 | 789,400 | |
| $0.480 | +0.012 | +2.6% | $0.463 | $0.487 | $0.450 | 1,811,300 | |
| $0.468 | -0.003 | -0.6% | $0.465 | $0.482 | $0.451 | 2,755,200 | |
| $0.471 | -0.054 | -10.3% | $0.525 | $0.539 | $0.470 | 1,234,000 | |
| $0.525 | +0.025 | +5.0% | $0.500 | $0.534 | $0.472 | 2,989,400 | |
| $0.500 | -0.050 | -9.1% | $0.560 | $0.560 | $0.480 | 2,689,500 | |
| $0.550 | -0.046 | -7.7% | $0.600 | $0.620 | $0.540 | 2,849,600 | |
| $0.596 | -0.082 | -12.1% | $0.678 | $0.689 | $0.590 | 2,278,600 | |
| $0.678 | -0.014 | -2.0% | $0.688 | $0.716 | $0.650 | 1,249,400 | |
| $0.692 | +0.014 | +2.1% | $0.648 | $0.747 | $0.641 | 3,402,600 | |
| $0.678 | -0.025 | -3.6% | $0.692 | $0.711 | $0.633 | 2,315,400 | |
| $0.703 | -0.028 | -3.8% | $0.746 | $0.773 | $0.693 | 1,426,600 | |
| $0.731 | -0.048 | -6.2% | $0.768 | $0.779 | $0.690 | 1,689,800 | |
| $0.779 | +0.087 | +12.6% | $0.696 | $0.811 | $0.690 | 3,211,900 | |
| $0.692 | -0.038 | -5.2% | $0.737 | $0.770 | $0.681 | 1,674,700 | |
| $0.730 | -0.020 | -2.7% | $0.741 | $0.764 | $0.710 | 3,882,700 | |
| $0.750 | -0.023 | -3.0% | $0.780 | $0.808 | $0.732 | 3,419,700 | |
| $0.773 | -0.058 | -7.0% | $0.844 | $0.892 | $0.760 | 3,214,600 | |
| $0.831 | -0.168 | -16.8% | $1.020 | $1.030 | $0.830 | 1,420,300 | |
| $0.999 | -0.041 | -3.9% | $1.030 | $1.060 | $0.990 | 552,900 | |
| $1.040 | -0.100 | -8.8% | $1.160 | $1.160 | $1.020 | 1,879,700 | |
| $1.140 | -0.060 | -5.0% | $1.200 | $1.210 | $1.115 | 600,800 | |
| $1.200 | -0.050 | -4.0% | $1.260 | $1.265 | $1.190 | 586,900 | |
| $1.250 | -0.060 | -4.6% | $1.290 | $1.340 | $1.240 | 757,200 | |
| $1.310 | -0.040 | -3.0% | $1.350 | $1.360 | $1.290 | 547,000 | |
| $1.350 | -0.030 | -2.2% | $1.390 | $1.390 | $1.340 | 386,000 | |
| $1.380 | +0.050 | +3.8% | $1.350 | $1.410 | $1.345 | 532,200 | |
| $1.330 | 0.000 | 0.0% | $1.330 | $1.360 | $1.310 | 532,600 | |
| $1.330 | -0.060 | -4.3% | $1.400 | $1.445 | $1.320 | 632,400 | |
| $1.390 | -0.090 | -6.1% | $1.500 | $1.510 | $1.380 | 695,800 | |
| $1.480 | -0.080 | -5.1% | $1.550 | $1.575 | $1.480 | 533,900 | |
| $1.560 | +0.060 | +4.0% | $1.500 | $1.570 | $1.460 | 535,900 | |
| $1.500 | -0.025 | -1.6% | $1.530 | $1.570 | $1.480 | 475,567 | |
| $1.525 | -0.105 | -6.4% | $1.580 | $1.650 | $1.510 | 1,155,384 | |
| $1.630 | +0.115 | +7.6% | $1.510 | $1.640 | $1.510 | 498,600 | |
| $1.515 | -0.125 | -7.6% | $1.610 | $1.630 | $1.475 | 1,485,500 | |
| $1.640 | 0.000 | 0.0% | $1.650 | $1.710 | $1.615 | 716,100 | |
| $1.640 | +0.120 | +7.9% | $1.500 | $1.650 | $1.480 | 781,400 | |
| $1.520 | -0.080 | -5.0% | $1.550 | $1.585 | $1.460 | 1,352,700 | |
| $1.600 | -0.130 | -7.5% | $1.690 | $1.710 | $1.580 | 1,165,500 | |
| $1.730 | +0.020 | +1.2% | $1.710 | $1.785 | $1.675 | 488,300 | |
| $1.710 | +0.010 | +0.6% | $1.700 | $1.760 | $1.675 | 351,600 | |
| $1.700 | +0.080 | +4.9% | $1.620 | $1.700 | $1.610 | 517,500 | |
| $1.620 | -0.010 | -0.6% | $1.650 | $1.660 | $1.570 | 580,793 | |
| $1.630 | -0.010 | -0.6% | $1.640 | $1.680 | $1.620 | 687,300 | |
| $1.640 | +0.030 | +1.9% | $1.610 | $1.670 | $1.600 | 345,400 | |
| $1.610 | +0.010 | +0.6% | $1.580 | $1.655 | $1.540 | 656,000 | |
| $1.600 | -0.040 | -2.4% | $1.640 | $1.690 | $1.580 | 830,900 | |
| $1.640 | +0.030 | +1.9% | $1.620 | $1.690 | $1.610 | 392,500 | |
| $1.610 | -0.040 | -2.4% | $1.560 | $1.610 | $1.480 | 1,628,100 | |
| $1.650 | 0.000 | 0.0% | $1.650 | $1.685 | $1.620 | 509,700 |
- Ticker
- NASDAQ:NMRA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Aug 14, 2026
Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Latest earnings call · Mar 30, 2026
Neumora Therapeutics (NASDAQ:NMRA) Q4 2025 Earnings Call
Replay and transcript
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 37 slides
Calls
Replays
Neumora Therapeutics (NASDAQ:NMRA) Q4 2025 Earnings Call
Mon, Mar 30, 2026 · 8:00 AM ET
Watch TranscriptNeumora Therapeutics (NASDAQ:NMRA) Q2 2025 Earnings Call
Wed, Aug 06, 2025 · 4:30 PM ET
Watch TranscriptNeumora Therapeutics (NASDAQ:NMRA) Q1 2025 Earnings Call
Mon, May 12, 2025 · 4:30 PM ET
Watch Transcript
Latest news
Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 14, 2026
Closed $1.60 (-7.5%) on Aug 14, 2026
Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026
Jul 27, 2026
Closed $1.66 (+11.4%) on Jul 27, 2026
Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update
Jun 15, 2026
Closed $0.915 (-48.6%) on Jun 15, 2026
Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference
May 12, 2026
Closed $1.78 (-6.3%) on May 13, 2026
Neumora Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 7, 2026
Closed $1.94 (-16.7%) on May 7, 2026
Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference
Apr 6, 2026
Closed $2.12 (+6.0%) on Apr 6, 2026
Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Mar 30, 2026
Closed $1.93 (-17.2%) on Mar 30, 2026
Neumora Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, March 30, 2026
Mar 16, 2026
Closed $2.87 (-4.3%) on Mar 16, 2026
Neumora Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
Feb 4, 2026
Closed $2.02 (-1.0%) on Feb 4, 2026
Neumora Therapeutics Highlights 2026 Pipeline Strategy and Anticipated Upcoming Milestones
Jan 5, 2026
Closed $1.64 (-1.5%) on Jan 5, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 37 slides · August 2026
Investor Presentation (June 2026)
Investor deck · 41 slides · June 2026
Investor Presentation (May 2026)
Investor deck · 46 slides · May 2026
Investor Presentation (March 2026)
Investor deck · 45 slides · March 2026
Neumora Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 13 in the last 12 months · 43 in all · newest Aug 14, 2026 · oldest 2023
- Calls
- 5 calls with a replay · 5 with a transcript · latest Mar 30, 2026
- Decks
- 15 decks · latest August 2026
Where Neumora Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:NMRA · Home listing · This page | NASDAQ | United States | USD |
| BOATS:NMRA | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Neumora Therapeutics, Inc.